Indications and usage:
ATF-Long is used as part of complex therapy in the following cases:
– Exertional stenocardia and resting stenocardia;
– Unstable stenocardia;
– Myocardial cardiosclerosis and postinfarction cardiosclerosis (local and diffuse);
– Supra-ventricular tachycardia, paroxysmal tachycardia;
– Vegetovascular dystonia;
– Other heart rhythm disorders.
ATF-Long is used in hyperuricemia of various origin, chronic fatigue syndrome, as well as in order to improve tolerance towards physical activities.
Dosage and administrations:
10-40 mg 3-4 times a day. Average treatment duration is 20-30 days. Retreatment course in 10-15 days may be given.
Treatment of arrhythmia and acute cardiological conditions: single dose (10-40 mg) is administered in 10 minutes after acute symptomatology reversal. Maximum daily dose is 400-600 mg.
Adverse effects: occasionally – nausea, abdominal pain and sense of discomfort, allergic reactions. In case of long-term and uncontrolled administration – hypermagnesaemia and hyperkalemia.
ATF-Long is contraindicated in patients with acute myocardial infarction, hypermagnesaemia and hyperkalemia, severe forms of bronchial asthma, haemorrhagic stroke, AV blockade of II-III stage, hypersensitivity to drug components. ATF-Long is not used in pregnant and breast-feeding women.
Pregnancy and lactation period: there is no information on safety and efficacy of ATF-Long administration in pregnant women. Breast-feeding women should not use ATF-Long.
Overdosage: symptoms: brachycardia, arterial hypotension and atrio-ventricular block.
Treatment: in case of the following side effects the medication should be immediately withdrawn. In case of brachycardia the injection of atropine sulfate is needed.